Mayapada Healthcare is revolutionising cancer care in Indonesia by integrating global medical innovations at its Oncology Centre.
The centre, located at Mayapada Hospital Jakarta Selatan, now offers advanced treatments such as precision oncology, robotic-assisted surgery, nuclear medicine, and theranostics. These advancements aim to provide personalised and internationally standardised cancer care.
The recent Mayapada HOPE 2026 event highlighted these innovations, bringing together international and local oncology experts to discuss the latest in cancer treatment.
A significant achievement was the successful robotic-assisted mastectomy performed by an Indonesian surgeon, showcasing the hospital’s capability in adopting advanced surgical techniques.
Navin Sonthalia, President Director and CEO of Mayapada Healthcare, emphasised the importance of supporting skilled Indonesian doctors with cutting-edge technology and multidisciplinary collaboration.
“Through Mayapada HOPE 2026, we demonstrate the capabilities of Mayapada Hospital’s Oncology Centre in delivering increasingly advanced, precise, and personalised cancer care,” he stated.
The hospital’s approach includes multidisciplinary collaboration through Tumour Boards, where specialists devise personalised treatment strategies. This is complemented by Patient Navigators who provide coordinated care and support throughout the treatment journey.
The integration of robotic technology allows for minimally invasive surgeries, enhancing precision and reducing recovery times. Prof. Sanjai Kumar Addla from Apollo Hospitals, India, noted that robotic surgery is now integral to modern surgical practice, offering significant clinical benefits.
Mayapada Healthcare’s commitment to advancing cancer care reflects its dedication to improving patient outcomes and aligning with global oncology standards.
The availability of advanced diagnostic tools like PET and SPECT scans further supports precise cancer care, enabling patients to access high-quality services within Indonesia.
“`
